1 Department of Neurology, Medical University of Innsbruck , Innsbruck, Austria .
2 Montreal Neurological Institute, McGill University , Montreal, Canada .
J Womens Health (Larchmt). 2018 Apr;27(4):525-530. doi: 10.1089/jwh.2017.6482. Epub 2018 Jan 22.
Previous studies have shown that women have less access or longer waiting times to high-tech medicine compared with men. This study aimed to detect possible gender differences in access to the diagnostic high-tech method of polysomnography (PSG). Furthermore, the study explored gender differences in prevalence of specific sleep diseases.
Source data of n = 1000 patients, who underwent PSG at the Medical University of Innsbruck, were reviewed. Clinical data regarding time elapsed between symptom onset and PSG as well as final diagnoses were analyzed for gender differences.
Six hundred sixty-nine men and 331 women were examined with PSG. There were no gender differences in access to PSG after first presentation to the sleep laboratory. Significantly more men than women (13.3 vs. 6.9%) were referred to medical examination because of abnormal observations by their bed partner. In men we found more sleep-related breathing disorders and fragmentary myoclonus, whereas in women insomnia was more common. Sleep-related breathing disorders showed a more severe manifestation in men, however, there was no difference in treatment with continuous positive airway pressure/biphasic positive airway pressure therapy between male and female patients.
Twice as many men than women received a PSG. This is explained by the referral rates to the sleep laboratory. While there are well-established gender differences for some sleep disorders, the fact that twice as many men than women were referred to the sleep laboratory could indicate a lower awareness for sleep disorders in women.
先前的研究表明,与男性相比,女性获得高科技医学的机会较少或等待时间更长。本研究旨在检测诊断性高科技方法多导睡眠图(PSG)获取方面可能存在的性别差异。此外,该研究还探讨了特定睡眠疾病患病率的性别差异。
回顾了在因斯布鲁克医科大学接受 PSG 检查的 n = 1000 名患者的源数据。分析了从症状出现到 PSG 以及最终诊断之间的时间间隔的临床数据,以检测性别差异。
669 名男性和 331 名女性接受了 PSG 检查。首次就诊于睡眠实验室后,男女接受 PSG 的机会没有差异。由于其床伴的异常观察,有更多的男性(13.3%比 6.9%)被转介到医疗检查。男性中更常见睡眠相关呼吸障碍和片段性肌阵挛,而女性中更常见失眠。然而,在男性和女性患者中,持续气道正压通气/双相气道正压通气治疗之间没有差异。男性的睡眠相关呼吸障碍表现更为严重。
接受 PSG 的男性是女性的两倍。这可以通过向睡眠实验室转诊率来解释。虽然一些睡眠障碍存在明确的性别差异,但有两倍多的男性比女性被转诊到睡眠实验室,这可能表明女性对睡眠障碍的认识较低。